112
Views
16
CrossRef citations to date
0
Altmetric
Biomarkers

High Serum Arginase I Levels in Asthma: its Correlation with High-Sensitivity C-Reactive Protein

, M.D., Ph.D., , M.D., Ph.D., , M.T., , M.D., , M.D., Ph.D., , M.D., Ph.D., , M.D., Ph.D. & , M.D., Ph.D. show all
Pages 1-7 | Published online: 01 Nov 2010

References

  • Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginasee. Comp Biochem Physiol B Biochem Mol Biol 1996; 114: 107–132.
  • Que LG. Kantrow SP, Jenkinson CP, Piantadosi CA, Huang YC. Induction of arginase isoforms in the lung during hyperoxia. Am J Physiol 1998; 275:L96–L102.
  • Klasen S, Hammermann R, Fuhrmann M, Lingemann D, Beck KF, Pfeilschifter J, Racke K. Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol 2001; 132:1349–1357.
  • Meurs H, Mckay S, Marrsingh H, Hamer MA, Macic L, Molendijk N, Increased arginase activity underlies allergen-induced deficiency of cNOS-dreived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 2002; 136:391–398.
  • Spector EB, Rice SCH, Hendrickson R, Cederbaum SD. Comparison of arginase activity in red blood cells of lower mammals, primates, and man: Evolution to high activity in primates. Am J Hum Genet 1985; 37:1138–1145.
  • Arginase: VD. Marker, effector, or candidate gene for asthma? J Clin Invest 2003; 111:1815–1817.
  • Zimmermann N, King NE, Laporte J, Yang M, Mishira A, Pope SM, Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003; 111:1863–1874.
  • Takemoto K, Ogino K, Shibamori M, Gondo T, Hitomi Y, Yakigawa T, Paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am J Physiol Lung Cell Mol Physiol 2007; 293:L1419–L1426.
  • Maarsingh H, Zuidhof AB, Bos IS, von Duin M, Boucher JL, Zaagoma J, Arginase inhibition protect against allergic airway obstruction, hyperresponsiveness & inflammation. Am J Respir Crit Care Med 2008; 178:565–573.
  • North ML, Khanna N, Marsden PA, Grasemann H, Scott JA. Functionally important for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 296:L911–L920.
  • Yang M, Rangasamy D, Matthaei KI, Zimmermann N, Mchalingam S, Webb DC, Inhibition of arginase I activity by RNA interferance IL-13-induced airways hyperresponsiveness. J Immunol 2006; 177:5595–5603.
  • Morris CR, Poljakovic M, Lavrisha L, Mochando L, Kuypers FA, Morris SM Jr.. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004; 170:148–153.
  • Lara A, Khatri SB, Wang Z, Comhair SA, Xu W, Dweik RA, National heart, lung, and blood institute's severe asthma research program. Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med 2008; 178:673–681.
  • Kocyigit A, Zeyrek D, Kekes H, Koylu A. Relationship among manganese, arginase, and nitric oxide in childhood asthma. Biol Trace Elem Res 2004; 102:11–18.
  • Ceylan E, Aksoy N, Gencer M, Evaluation of oxidative-anitioxidative status and the L-arginine-nitric oxide pathway in asthmatic patients. Respir Med 2005; 99:871–876.
  • Yang BK, Vivas EX, Reiter CD, Gladwin MT. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic Res 2003; 37:1–10.
  • Zharikov S, Krotova K, Hu H, Vural H, Keles H, Seleck S. Uric acid decreases NO production and increases arginase activity in cultures pulmonary artery endothelial cells. Am J Physiolo Cell Physiol 2008; 295:1183–1190.
  • Porembska Z, Zabek J, Grabon W, Rahden-Staron I, Baranczyk-Kuzma A. Arginase isoforms in human coleorectal cancer. Clin Chim Acta 2001; 305:157–165.
  • Wang SR, Chen ML, Huang MH, Lin HY, Tsai JJ, Kuo BI. Plasma arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population. Clin Biochem 1993; 26:455–460.
  • Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steimberg MH, Erythrocyte glutamine depletion, altered redox environment, and pulmonary hepertension in sickle cell disease. Blood 2008; 111:402–410.
  • Bergeron C, Boulet LP, Page N, Laviolette M, Zimmermann N, Rothenberg ME, Influence of cigarette smoke on the arginine pathway in asthmatic airwaya: Increased expression of arginase I. J Allergy Clin Immunol 2007; 119:391–397.
  • Tang RB, Chen SJ. Soluble interleukin-2 receptor and interleukin-4 in sera of asthmatic children before and after a prednisolone course. Ann Allergy Asthma Immunol 2001; 86:314–317.
  • Tsai TC, Lu JH, Chen SJ, Tang RB. Soluble interleukin-10 and transforming growth factor-beta in children with acute exacerbation of allergic asthma. J Asthma 2009; 46:21–24.
  • Ozyilmaz E, Canbakan S, Capan N, Erfurk A, Gulham M. Correlation of plasma transforming growth factor beta 1 with asthma control test. Allergy Asthma Proc 2009; 30:35–40.
  • Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemenn WP, Henson PM. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 2006; 281:38376–38384.
  • Louis CA, Mody V, Henry WL Jr, Reichner JS, Albina JE. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am J Physiol 1999; 276:R237–R242.
  • Pepys MB. C-reactive protein fifty years on. Lancet 1981; 1:653–657.
  • Pepys MB, Baltz MC. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34:141–212.
  • Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Clin Chem 2000; 46:461–468.
  • Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 2001; 286:327–334.
  • Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other marers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836–843.
  • Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gisiason D, Jogi R, C reactive protein levels are increased in non-allergic but not allergic asthma: A multicentre epidemiological study. Thorax 2005; 60:451–454.
  • Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, Mroczko B, Szmitkowski M, Bodzenta-Lukaszyk A. High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma. Respir Med 2009; 103:379–385.
  • Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, High sensitivity C-reactive protein in asthma. Eur Respir J 2006; 27:908–912.
  • Nakayama T, Sonoda S, Urano T, Yamada T, Okada M. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious disease. Clin Chem 1993; 39:293–297.
  • Munder M, Mollinedo F, Calafat J, Gil-Lamaignere C, Fuentes JM, Luckner C, Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 2006; 105:2549–2556.
  • Munder M. Arginase: An emerging key player in the mammalian immune system. Br J Pharmacol 2009; 158:638–651.
  • Litonjua AA, Lasy-Su J, Schneiter K, Tantisira KG, Lazarus R, Klanderman B, ARG1 is a novel bronchodilator response gene. Screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008; 178:688–694.
  • Salam MT, Islam T, Gauderman WJ, Gilliland FD. Role of arginase variants, atopy, and ozone in childhood asthma. J Allergy Clin Immunol 2009; 123:596–602.
  • Vonk JM, Postma DS, Maarsingh H, Bruinenberg M, Koppelman GH, Meurs H. Arginase 1 and arginase 2 variations associated with asthma, asthma severity and beta 2 agonist and steroid response. Pharmacogenet Genomics. 2010; 20:179–186.
  • Unal M, Eskandari HG, Ercetin N, Dogruer ZN, Pata YS. Serum nitrite/nitrate and arginase levels in patients with allergic rhinitis. ORL J Otorhinolarynngol Relat Spec 2007; 69:113–115.
  • Lindemann D, Racke K. Glucocorticoid inhibition of interleulin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 2003; 368:546–550.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.